1-5 of 5
Stefan Hubner
Close
Sort by
Journal Articles

A STAT3 Degrader Demonstrates Pre-Clinical Efficacy in Venetoclax Resistant Acute Myeloid Leukemia

Samarpana Chakraborty, Claudia Morganti, Joyoti Dey, Hui Zhang, Srinivas Aluri, Nadege Gitego, Kith Pradhan, Bianca Rivera, Yogesh Chutake, Anna Skwarska, Ioannis Mantzaris, Mendel Goldfinger, Eric J Feldman, Gaurav S Choudhary, Stefan Hubner, Yihua Qiu, Brandon D. Brown, Amit Verma, Evripidis Gavathiotis, Marina Y. Konopleva, Steven M. Kornblau, Jared Gollob, Keisuke Ito, Aditi Shastri
Journal: Blood
Blood (2023) 142 (Supplement 1): 2787.
https://doi.org/10.1182/blood-2023-186947
Published: 2023
Journal Articles

Optimizing FLT3 Inhibitor Use in Adult Acute Myeloid Leukemia with FLT3 Mutations Using Proteomics

Eduardo Sabino Magalhaes, Stefan Hubner, Brandon D. Brown, Yihua Qiu, Steven M. Kornblau
Journal: Blood
Blood (2023) 142 (Supplement 1): 165.
https://doi.org/10.1182/blood-2023-186508
Published: 2023
Journal Articles

Proteomic Profiling Identifies Unique IDH Mutant Signatures and Novel Therapeutic Opportunities in Adult Acute Myeloid Leukemia Patients

Eduardo Sabino de Camargo Magalhaes, Stefan Hubner, Brandon D. Brown, Yihua Qiu, Steven M. Kornblau
Journal: Blood
Blood (2023) 142 (Supplement 1): 1581.
https://doi.org/10.1182/blood-2023-186723
Published: 2023
Journal Articles

Targeting Vimentin (VIM) in Acute Myelogenous Leukemia (AML)

Stefan Hubner, Marina Konopleva, Zhihong Zeng, Fieke W Hoff, Yihua Qiu, Vivian Ruvolo, Terzah M. Horton, Steven M. Kornblau
Journal: Blood
Blood (2022) 140 (Supplement 1): 6260–6261.
https://doi.org/10.1182/blood-2022-163664
Published: 2022
Journal Articles

Proteomics-Based Strategy for the Recommendation of Conventional Chemotherapy Vs Venetoclax Plus Hypomethylating Agents in Adult Acute Myeloid Leukemia (AML)

Eduardo Sabino de Camargo Magalhaes, Brandon D Brown, Stefan Hubner, Yihua Qiu, Steven M. Kornblau
Journal: Blood
Blood (2022) 140 (Supplement 1): 6312–6313.
https://doi.org/10.1182/blood-2022-165158
Published: 2022